Evidence map›Paper›PMID 39812863›Full record

ArticleJournal of neurology2025

Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson's.

Jennifer R Mammen, Aaron Lerner, Raunak Al-Rubayie, Melissa Kostrzebski, Diane Stephenson, Yuge Xiao, Chris Redmond, Mirinda Tyo, Varun G Reddy, Peggy Auinger and 2 more

Abstract read
In one paragraph

Article in Journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Examining the lived experience of dementia with Lewy bodies through qualitative research: A systematic review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Multidimensional pain patterns in Parkinson's disease: a longitudinal mobile health study.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  4. Review
  5. Digital Technologies for Symptom Monitoring in Parkinson Disease.Current neurology and neuroscience reports · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Developing digital health technologies for frontotemporal degeneration.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jennifer R MammenCollege of Nursing and Health Sciences, University of Massachusetts, Dartmouth, Dartmouth, USA. jmammen@umassd.edu.ORCID http://orcid.org/0000-0001-7858-9183
Aaron LernerCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Raunak Al-RubayieCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Melissa KostrzebskiCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Diane StephensonCritical Path Institute, Tucson, USA.
Yuge XiaoMichael J Fox Foundation for Parkinson's Research, New York, USA.
Chris RedmondPerson With Parkinson's Disease, New York, USA.
Mirinda TyoCollege of Nursing and Health Sciences, University of Massachusetts, Dartmouth, Dartmouth, USA.
Varun G ReddyCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Peggy AuingerCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
E Ray DorseyCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.
Jamie L AdamsCenter for Health + Technology, University of Rochester Medical Center, Rochester, NY, USA.

Funding

Michael J. Fox Foundation for Parkinson's Research MJFF-022743
6 · The paper itself

Abstract

backgroundLongitudinal qualitative data on what matters to people with Parkinson's disease are lacking and needed to guide patient-centered clinical care and development of outcome measures.

objectiveTo evaluate change over time in symptoms, impacts, and relevance of digital measures to monitor disease progression in early Parkinson's.

methodsIn-depth, online symptom mapping interviews were conducted with 33 people with early Parkinson's at baseline and 1 year later to evaluate (A) symptoms, (B) impacts, and (C) relevance of digital measures to monitor personally relevant symptoms. Maps and transcripts were coded for frequencies, Likert scale rankings (0 = not present to 4 = most bothersome), and thematic findings. Wilcoxon Signed Rank test was used to evaluate change over time.

resultsOther than walking and balance, most motor symptoms did not change significantly from baseline to 1 year later. Multiple significant changes were observed in non-motor areas (cognition, speech, sleep, mood, fatigue, pain; p < 0.05) and functional impacts (mobility, effort to do usual activities, personal comfort; p < 0.05). Thematic analysis revealed ability to cope with and compensate for actual or anticipated symptoms reduced disruptions to well-being and changed how bothersome symptoms were. All digital measures targeted symptoms that were personally important to most participants (> 80%).

conclusionNon-motor and walking/balance symptoms changed sooner than other motor symptoms during the course of 1 year. Evaluation of coping and compensatory mechanisms may be essential to understanding symptom bothersomeness at a given point in time. Smartphone and smartwatch digital measures were relevant to personally meaningful symptoms of early PD.

Indexed as

Parkinson DiseaseAgedDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedQualitative ResearchDigital health technologyParkinson’sPatient experienceQualitativeSymptoms

Identifiers

PMID39812863
PMCPMC11735495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.